This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2022, 18, 837–844, doi:10.3762/bjoc.18.84
Graphical Abstract
Figure 1: FDA-approved HDAC inhibitors with a hydroxamic acid moiety.
Scheme 1: Synthesis of compounds 3–18. Reagents and conditions: (a) ethyl 2-bromoethanoate, TBAB, TEA, 50–60 ...
Scheme 2: Synthesis of compounds 20–31. Reagents and conditions: (a) ethyl 2-bromoethanoate (for 22) (or ethy...
Figure 2: The conformational and tautomeric forms of hydroxamic acids according to [36].
Figure 3: Fragment of the 1H NMR spectrum in DMSO-d6 of compound 12.
Beilstein J. Org. Chem. 2013, 9, 1819–1825, doi:10.3762/bjoc.9.212
Scheme 1: General behavior of electrophilic and nucleophilic substitution reactions of pyrimidines.
Scheme 2: Our previous results.
Scheme 3: Reagents and conditions: i: NaNO2 (1.2 equiv), AcOH, rt; 1a,2a: R = H; R1 = Me; 1b,2b: R = H; R1 = ...
Scheme 4: N-Denitrosation reaction and intramolecular nitroso group transfer reactions in 6,-N-disubstituted-N...
Scheme 5: The classical Fischer–Hepp rearrangement.
Scheme 6: One-pot nucleophilic substitution and nitroso group migration in N-benzyl-4-chloro-6-morpholino-N-n...